AKT1 and neoplasm: This occurs as a result of mutations, re-activation of key pathways including MAPK/ERK and phosphatidylinositol 3-kinase/protein kinase B (PI3K/Akt), and changes in the cells’ interactions with the tumor microenvironment in melanoma tumors.